Application of CBD as drug for treating METH addiction
A technology for addictive drugs and uses, applied in the direction of drug combinations, active ingredients of hydroxyl compounds, nervous system diseases, etc., can solve the problems of no effective drugs for drug addiction, drug abuse and unknown molecular mechanism of addiction, etc. achieve better therapeutic effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] Example 1 Establishment of a METH-dependent rat CPP model.
[0023] experiment method:
[0024] 70 male SD rats (180-220 g) were purchased from the Experimental Animal Center of Kunming Medical University. All rats were housed in a temperature-controlled room (23°C ± 1°C), rats could drink food and water freely, and after a 12-hour light / dark cycle, all rats were acclimated to the environment in the CPP device for 3 days before the experiment was performed .
Embodiment 2
[0025] Embodiment 2 carries out CPP experiment, detects the effect of CBD on METH inducing CPP
[0026] 1. Test method:
[0027] CBD was dissolved in physiological saline solution of 5% dimethyl sulfoxide and 5% Tween 80 and injected intraperitoneally at doses of 10, 20, 40, and 80 mg / kg. The effects of different concentrations of CBD (10, 20, 40, 80 mg / kg) on METH-induced CPP were observed. Rats were randomly divided into 7 groups: control group (normal saline, 10ml / kg, ip), METH group (METH, 2mg / kg, ip), CBD group (CBD, 40mg / kg, ip), CBD (10mg / kg) kg)+METH group, CBD(20mg / kg)+METH group, CBD(40mg / kg)+METH group and CBD(80mg / kg)+METH group. Rats were intraperitoneally injected with CBD (10, 20, 40, 80 mg / kg) or saline for 1 h, and then intraperitoneally injected with METH (2 mg / kg) or saline (10 ml / kg).
[0028] CPP experimental protocols such as figure 1 As shown in (a), it consists of three stages:
[0029] On days 1-3, each rat was free to move between the black and...
Embodiment 3
[0035] The expression changes of Sigma1R, AKT, p-AKT, GSK-3β, p-GSK-3β, CERB and p-CREB in four brain regions were detected by WesternBlot.
[0036] 1. Test method
[0037] After killing the rats, the rat brain tissue was placed on ice, and the prefrontal cortex, hippocampus, nucleus accumbens and ventral tegmental area were isolated and stored at -80°C for later use. Brain tissue was lysed with enhanced RIPA protein lysis buffer containing 1% PMSF and protease inhibitors. The protein concentration was detected using the BCA protein assay kit. Equal amounts (25 μg) of protein were separated by 12% SDS-PAGE and transferred to 0.45 μm PVDF membranes. The PVDF membrane was blocked with 5% nonfat milk at room temperature for 2 hours, and the primary antibody (1:1000) was added overnight in a refrigerator at 4°C. Subsequently, secondary antibody (1:5 000) was added and incubated at room temperature for 1 h, the membrane was washed 10 min×4 times with TBST, developed with ECL chr...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com